We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Wireless Monitoring Facilitates Cardiac Patient Management

By HospiMedica International staff writers
Posted on 22 Dec 2015
A new remote cardiac rhythm monitor incorporates complete mobile cardiac telemetry (MCT), Holter, and cellular event monitoring. More...


The 3-1 TeleSense device is a comfortable to wear, simple to set up, and configurable device for the auto-detection of arrhythmia events and concomitant wireless transmission of three-channel electrocardiogram (ECG) data, thus allowing clinicians to more accurately correlate between patient symptoms and changes in the electrical conduction of the heart. A web-accessible platform supports detailed and actionable reporting through daily event reports, heart rate trends reports, and end-of-session reports; interim and summary statistics; and advanced administrative and clinical queries.

The device can transmit up to 30 days of continuous ECG data across multiple cellular networks or by utilizing a patient’s own WiFi network. For clinicians unable to offer patients 24-hour monitoring coverage, an optional dedicated monitoring service provides active daily surveillance and reporting capabilities, as well as immediate access to raw data and completed reports from any internet connected computer. Optional electronic health record (EHR) integration enables reports to be easily viewed and e-signed by the physician prior to automated transmission.

Brightly-lit icons allow the patient to easily identify whether the device has sufficient power, whether leads are properly connected, if the device is recording, and the status of the WiFi or cellular connection. Patients can also quickly record and immediately transmit self-identified events via a large, easily accessible button on the front of the device, helping to address the continuous concern of patient compliance. The 3-1 TeleSense device is a product of ScottCare (Cleveland, OH, USA).

“We created TeleSense with the goal of providing clinicians with an easy-to-use, comprehensive monitoring device they could trust for diagnostic accuracy, technological reliability and improved patient compliance,” said Sneh Merchant, vice president of research and development at ScottCare. “They can depend on TeleSense to help them care for their cardiac event patients in a highly convenient and effective way.”

Related Links:

ScottCare



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Pediatric Mask
Respire SOFT
New
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.